SEVOflurane Inhalation in CARdiac Arrest Resuscitated Patients Treated With Therapeutic Hypothermia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-07-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studying the feasibility of an initial sedation with inhalated sevoflurane during therapeutic hypothermia of cardiac arrests resuscitated patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Comparison of Inhalation vs. Intravenous Induction

NCT02331108

Hypothermia

COMPLETED NA

Inhaled Sevoflurane for ARDS Prevention

NCT05849779

Acute Respiratory Distress Syndrome

RECRUITING PHASE3

SEvoflurane for Sedation in ARds

NCT04235608

Acute Respiratory Distress Syndrome

COMPLETED PHASE3

Interest of the Induction With Target-controlled Inhalation of Sevoflurane on Spikes Wave Occurrence

NCT00775879

General Anesthesia

COMPLETED NA

The Effect of Sevoflurane on Cerebral CO2 Sensitivity and Systemic Arteries

NCT02054143

Sevoflurane Anesthesia

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective clinical study in ICU with ventilated patients sedated with sevoflurane using the Mirus® and Anaconda® , establishing the feasibility of an initial sedation of patients resuscitated from cardiac arrest and treated with therapeutic hypothermia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Arrest Therapeutic Hypothermia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

sevoflurane

Group Type OTHER

sevoflurane

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sevoflurane

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* -Adult patients ventilated requiring therapeutic hypothermia in ICU
* Stable respiratory and hemodynamic conditions
* Epinephrine and norepinephrine infusion rate \< 1,5 g/kg/min
* Consent of patients or family
* Arterial line
* Patients resuscitated after cardiac arrest
* No Flow \< 10 min
* Low Flow \< 20 min
* Neutropenia \< 1 G/L
* Post traumatic cardiac arrest
* Contraindication of halogenated anesthesics
* Extra corporeal life support or intra aortic balloon pump